tirzepatide semaglutide mechanism of action (MOA) of Semaglutide vs Tirzepatide for Weight
Description
This optional intermediate step exists primarily for individuals who tolerate 10 mg well but have not achieved desired weight loss goals
Protocols, doses, and reactions reported below come from clinical trials and community sources
With these methods, assuming no difference in cardiovascular risk between tirzepatide and comparators, it was determined that 133 participants with MACE-4 would provide 90% power to exclude the upper limit of the 95% CI of 1.8 at two-sided alpha = 0.05
Start Your Weight Loss Journey Now
Two commonly used GLP-1 agonists are Semaglutide and Tirzepatide
